Shimizu Kentaro, Hirose Tomoya, Ogura Hiroshi
Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
J Intensive Care. 2021 Oct 15;9(1):62. doi: 10.1186/s40560-021-00567-3.
We comment on the study by Batra et al. on the efficacy of probiotics in the prevention of ventilator-associated pneumonia in critically ill ICU patients. They also reported that probiotics administration was not associated with a statistically significant reduction in the incidence of diarrhea (OR 0.59; CI 0.34, 1.03; P = 0.06; I = 38%). However, their meta-analysis missed one RCT, and when we repeated the analysis including this RCT, we found that probiotics administration significantly reduced the incidence of diarrhea (OR 0.51; CI 0.28, 0.92; P = 0.02; I = 45.6%). We thus believe that probiotics administration is effective in reducing the incidence of diarrhea in ventilated critically ill ICU patients.
我们对巴特拉等人关于益生菌预防重症监护病房(ICU)危重患者呼吸机相关性肺炎疗效的研究进行评论。他们还报告称,给予益生菌与腹泻发生率的统计学显著降低无关(比值比[OR]0.59;可信区间[CI]0.34,1.03;P = 0.06;异质性指数[I] = 38%)。然而,他们的荟萃分析遗漏了一项随机对照试验(RCT),当我们重复该分析并纳入这项RCT时,我们发现给予益生菌显著降低了腹泻发生率(OR 0.51;CI 0.28,0.92;P = 0.02;I = 45.6%)。因此,我们认为给予益生菌可有效降低接受机械通气的ICU危重患者的腹泻发生率。